Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Inhibitors of gangliosides metabolism for the treatment of motor neuron diseases

Inhibitors of gangliosides metabolism for the treatment of motor neuron diseases

US Patent 11065238 · Granted Jul 20, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Diagnosis of hereditary spastic paraplegias (HSP) by detection of a mutation in 2019
Anaplerotic therapy of huntington disease and other polyglutamine diseases2019
Triheptanoin for the treatment of glucose transport 1 deficiency2018
Urinary triaosylceramide (Gb3) as a marker of cardiac disease2017
Anaplerotic therapy of huntington disease and other polyglutamine diseases2017
Diagnosis of hereditary spastic paraplegias (HSP) by detection of a mutation in 2017
Diagnosis of hereditary spastic paraplegias (HSP) by identification of a mutatio2016
Triheptanoin for the treatment of glucose transport 1 deficiency2016
Urinary triaosylceramide (GB3) as a marker of cardiac disease2015
Diagnosis of hereditary spastic paraplegias (HSP) by detection of a mutation in 2014